New heart drug shows promise in thick heart muscle trial
Disease control
Completed
This study tested a new drug called CK-3773274 (aficamten) in 96 adults with symptomatic hypertrophic cardiomyopathy, a condition where the heart muscle is abnormally thick. The goal was to find the best dose that is safe and improves heart function. Participants received either …
Phase: PHASE2 • Sponsor: Cytokinetics • Aim: Disease control
Last updated Apr 26, 2026 19:36 UTC